SCHEMBL31422840

SCHEMBL31422840

NC(=O)c1cc2cc(F)ccc2[nH]c1=O

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ DAO P14920 2/20 0.61
▸ KDM4E B2RXH2 3/20 0.53
▸ ALDH1A1 P00352 2/20 0.53
▸ PDPK1 O15530 1/20 0.53
▸ LMNA P02545 1/20 0.53
▸ HPGD P15428 1/20 0.53
▸ TSHR P16473 1/20 0.53
▸ NFKB1 P19838 1/20 0.53
▸ APEX1 P27695 1/20 0.53
▸ CYP2C19 P33261 1/20 0.53
▸ HSD17B10 Q99714 1/20 0.53
▸ TDP1 Q9NUW8 1/20 0.53
▸ FLT3 P36888 5/20 0.48
▸ POLB P06746 1/20 0.46
▸ GAA P10253 1/20 0.46
▸ DDO Q99489 1/20 0.45
▸ MLLT1 Q03111 1/20 0.42
▸ HRH4 Q9H3N8 1/20 0.42
▸ MAP2 P11137 1/20 0.40
▸ CDK5 Q00535 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31423165 0.87 DAO (0.61) DAOKDM4EALDH1A1PDPK1LMNA
SCHEMBL1368448 0.87 DAO (0.65) DAOKDM4EALDH1A1PDPK1LMNA
SCHEMBL19145616 0.86 DAO (0.59) DAOKDM4EALDH1A1PDPK1LMNA
SCHEMBL8500109 0.85 KDM4E (0.63) DAOKDM4EALDH1A1PDPK1LMNA
SCHEMBL16236492 0.82 FLT3 (0.53) DAOKDM4EALDH1A1HSD17B10FLT3
SCHEMBL19126580 0.80 DAO (0.56) DAOKDM4EALDH1A1PDPK1LMNA
SCHEMBL250527 0.78 KDM4E (0.72) DAOKDM4EALDH1A1PDPK1LMNA
SCHEMBL29390425 0.78 DAO (0.58) DAOKDM4EALDH1A1HPGDTSHR
SCHEMBL29537 0.78 DAO (0.58) DAOKDM4EALDH1A1HPGDTSHR
Hydrochloric Acid SCHEMBL30321479 0.77 DAO (0.56) DAOKDM4EALDH1A1HPGDTSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025085233-A1 NOVEL DERIVATIVES OF QUINOLINONES, AND COMPOSITIONS AND METHODS THEREOF ENSEM THERAPEUTICS, INC. (US) 2025-04-24 — — WO disclosed
Send feedback